Bussiness6 months ago
Jim Cramer says Eli Lilly isn’t a ‘one trick pony’ after FDA advisers endorse its Alzheimer’s drug
CNBC’s Jim Cramer on Tuesday explained why he continues to be bullish about pharmaceutical giant Eli Lilly. Continually confident about Eli Lilly because of the enormous...
